Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
0 %
$ 87.4 M
Market Cap
-0.88
P/E
INZY - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity INZY - Inozyme Pharma, Inc.
201 M
LAST VALUE
27.50%
2 YEAR CAGR
35.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR